Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Multi-Center, Double-Blind, 26 Week, Placebo-Controlled Trial of Memantine (10mg BID) for the Frontal and Temporal Subtypes of Frontotemporal Dementia

NCT00545974 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT00545974
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00545974 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Multi-Center, Double-Blind, 26 Week, Placebo-Controlled Trial of Memantine (10mg BID) for the Frontal and Temporal Subtypes of Frontotemporal Dementia
Lead sponsor
University of California, San Francisco
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2007
Completion date
December 31, 2012
Enrollment
81 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

frontal lobe dementia, frontotemporal lobe dementia, semantic dementia